Profil
Andrew Jefferson is currently an Operating Partner at Versant Ventures (Switzerland) GmbH since 2022.
Formerly, Mr. Jefferson was Chief Operating Officer at Monte Rosa Therapeutics, Inc. Mr. Jefferson completed an undergraduate degree at The University of Nottingham in 1990 and earned an MBA from the University of Brighton in 1999.
Postes actifs de Andrew Jefferson
| Sociétés | Poste | Début |
|---|---|---|
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/07/2022 |
Anciens postes connus de Andrew Jefferson
| Sociétés | Poste | Fin |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur des opérations | - |
Formation de Andrew Jefferson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
















